This inventor holds 2 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Pharmathen S.a., Vio Ag Pharmaceuticals S.a.. Active years: 2013-2021.
Company Filing History:
Years Active: 2013-2021
Title: Thanos Andreou: Innovator in Pharmaceutical Chemistry
Introduction
Thanos Andreou is a notable inventor based in Salonika, Greece. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative approaches to drug synthesis. With a total of 2 patents, Andreou has demonstrated his expertise and commitment to advancing pharmaceutical science.
Latest Patents
Thanos Andreou's latest patents include a novel process for the preparation of Vortioxetine and its key intermediate. This invention employs a one-pot organo-pseudocatalytic C—H activation approach via hypervalent iodine chemistry. Additionally, he has developed an improved process for the preparation of a propenal intermediate and its derivatives. This process is particularly useful for synthesizing a compound known as Rosuvastatin, which has significant therapeutic applications.
Career Highlights
Throughout his career, Thanos Andreou has worked with prominent companies in the pharmaceutical industry. Notable among these are Vio Ag Pharmaceuticals S.A. and Pharmathen S.A. His work in these organizations has allowed him to apply his innovative ideas and contribute to the development of important pharmaceutical products.
Collaborations
Thanos Andreou has collaborated with several professionals in his field, including Efstratios Neokosmidis and Theocharis V Koftis. These collaborations have further enriched his research and development efforts, leading to advancements in pharmaceutical chemistry.
Conclusion
Thanos Andreou is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect his dedication to improving drug synthesis processes, making a significant impact in the industry.